|
|
|||
|
ABOUT US |
|||
|
|
|||
|
About AriaVax |
| ||
|
Management |
|
|
|
|
|
Frank A. Robey |
||
|
|
Chief Scientific Officer |
||
|
|
Currently, Dr. Frank A. Robey is acting as Chief Scientific Officer. He is the primary inventor of the patents forming the basis of the Company’s intellectual property platform and the DeadlockTM technology. This technology was developed during his 15 years as a senior investigator at the NIH in Bethesda, MD. As a government scientist, Dr. Robey has produced out-licensed technology resulting in FDA-approved injectable products. He has also been a consultant on protein chemistry and FDA regulatory issues to many leading US biotech companies, including Centocor and Genentech.
Prior to his appointment at NIH, Dr. Robey spent over eight years at the Food and Drug Administration (FDA) where he held research positions in the Division of Bacterial Products, the vaccine branch of the FDA, and several lead positions formulating the Agency’s first responses to biotechnology, including products used to treat and diagnose AIDS. His knowledge of FDA processes and procedures are crucial to the Company’s ability to move drug candidates through the approval process quickly. |
||
|
|
|
|
|
|
|
|||
